Azova appoints new SVP of sales, operations

Press enter to search
Close search
Open Menu

Azova appoints new SVP of sales, operations

09/19/2018
Azova, a company focused on creating digital health platforms for pharmacies, patients, physicians and payers, announced a new addition to its leadership team.

The Salt Lake City-based company announced that Ashton S. Maaraba, the former head of the product and partners team at eRx network, would be its new senior vice president of sales and operations.

“I look forward to collaborating closely with Ashton as we leverage his deep industry intelligence, insights and skills in leading both our sales and operations, while continuing to innovate our core product offerings and business infrastructure,” Paul Ewing, chief technology officer at Azova, said.

Maaraba will be responsible for Azova’s retail pharmacy, physician, pharma, patient and payer divisions, as well as company operations.

"I am excited to join Azova,” Maaraba said. “This is a fast-growing and innovative company with top talent in digital health, telemedicine and telepharmacy. Azova has pioneered a new way to drive digital health services into workflow, connecting all the dots in the healthcare ecosystem into a single, integrated and cloud-based solution, while interfacing with pharmacy systems, physician EMRs, employer and payer group software systems, and the consumer. Azova opens the door for collaboration, portability and the ability to penetrate communication channels across a niche digital healthcare marketplace.”

Maaraba has 20 years of experience in the pharmaceutical, digital health, medical device and pharmacy services industries. He has held positions at PharmaSmart and Flavorx, and was on the advisory council for the National Association of Chain Drug Stores and RxImpact.

“Azova is excited to have Ashton join our leadership team,” Cheryl Lee Eberting, CEO and founder of Azova, said. “His passion, appetite for success, leadership and experience will be invaluable as we deploy our technology and strategy.”

RELATED TOPICS